(Reuters) – Moderna Inc said on Thursday it will develop a seasonal flu vaccine as part of its increased investment in vaccines.
The company also said it was actively preparing for a commercial launch of its potential COVID-19 vaccine.
(Reporting by Trisha Roy in Bengaluru; Editing by Shinjini Ganguli)
